Increased intravenous catheter use has been paralleled by increased bacterial and yeast bloodstream infection. Biofilm formation, which is associated with the cell surface hydrophobicity (CSH) phenotype, represents a major pathogenicity strategy ofCandida albicans, becoming especially important in the colonization of intravascular medical devices. Increasing evidence shows the induction of virulence factors inC. albicansby diverse substances. Therefore, we investigated whether rifampicin, an antibiotic shown to be capable of inducing MDR1 expression inC. albicansmay also promote the formation of a pathogenic biofilm. In response to 40 µg/mL rifampicin, an enhanced retention ofC. albicansSC5314 cells on polystyrene culture plates was observed by measuring increased metabolic activity by XTT assay, indicating induction of biofilm formation. Rifampicin treatment also induced fibronectin binding, cell hydrophobicity and germ tube formation. Furthermore, increased RNA and protein expression of CSH1p, a major mediator of CSH, was demonstrated. We conclude that exposure to rifampicin may result in upregulation of keyCandidavirulence determinants, potentially boosting pathogenicity and supporting biofilm formation. This finding gains clinical significance from the increasing popularity of rifampicin-coated catheters, which might provide an advantageous gateway forCandidabloodstream infections.